• Practice
  • About 22 min
  • 5 practice questions

Drugs, their classification and drug-target interactions

Define drug, medicine and chemotherapy, explain the therapeutic index, classify drugs in four ways, and explain how drugs act on enzymes (competitive and allosteric inhibition) and on receptors (agonists and antagonists).

If something looks wrong, please tell us.

By the end of this lesson you can

  • Define a drug, a medicine and chemotherapy, and describe an ideal drug.
  • Explain what the therapeutic index measures.
  • Classify drugs by chemical structure, pharmacological effect, target system and site of action.
  • Explain how drugs act on enzymes and receptors, with the examples in the textbook.

Food, clothes and shelter are all made of chemical compounds, and life itself is a set of linked chemical reactions. This last unit of the Tamil Nadu textbook looks at the chemistry of medicines, food additives, cleansing agents and polymers. This lesson explains what medicines are and how they act at the molecular level. It is chemistry, not medical advice: it gives no doses, and medicines are taken only as a doctor directs.

Drugs and medicines

The word drug comes from the French drogue, 'dry herb'. A drug is a substance used to modify or explore body systems or disease states for the benefit of the person receiving it, for diagnosis, prevention, cure or relief of a disease. A drug that acts on large molecules in the body, such as proteins, to give a useful therapeutic response is a medicine. Treating a disease with chemicals in this specific way is chemotherapy.

An ideal drug would be non-toxic, biocompatible and biodegradable, with no side effects. Most drugs come close to this only within a limited range of concentration; at higher concentrations they cause side effects and become toxic. The therapeutic index compares the largest amount the body tolerates (above which the drug is toxic) with the smallest amount that is effective. It is a ratio, so it has no unit, and the larger the therapeutic index, the safer the drug, because there is a wider gap between the effective level and the toxic level.

Worked example 1: reading therapeutic indices

Two made-up compounds are compared in a laboratory study. Compound P has a therapeutic index of 20 and compound Q a therapeutic index of 3. Which has the wider safety margin? Working: the index is the ratio (highest tolerated level) ÷ (lowest effective level). For P, the tolerated level is 20 times the effective level; for Q only 3 times. So P has the wider margin of safety; Q becomes toxic at a level only a little above the one at which it works, and would need much closer control.

Four ways to classify drugs

Classification of drugs

  • Chemical structure
    • Common skeleton, such as the penicillins (ampicillin, amoxicillin, methicillin)
    • Similar structure does not always mean similar action (barbiturates, steroids)
  • Pharmacological effect
    • Grouped by the effect produced
    • Antibiotics kill disease-causing bacteria; antihypertensives lower blood pressure
  • Target system
    • Grouped by the process affected
    • Streptomycin and erythromycin both stop bacterial protein synthesis, in different ways
  • Site of action
    • Grouped by the molecular target (enzyme or receptor)
    • Most specific; drugs share a mechanism

Classification by target system is more specific than by effect. Streptomycin and erythromycin both inhibit protein synthesis in bacteria, but streptomycin stops the start of synthesis, while erythromycin stops new amino acids from being added to the growing chain.

Drug-target interactions

The body's routine processes, such as metabolism (breaking down food to make ATP and building new molecules, all catalysed by enzymes) and cell signalling (receptors sensing a change and passing on a message), can be upset by microorganisms, chemicals or a disorder of the body itself. Drugs restore normal working by binding to drug targets, mainly proteins: enzymes (catalysts) and receptors (parts of the communication system).

Enzymes as drug targets

A substrate binds to an enzyme's active site through weak forces such as hydrogen bonds and van der Waals forces. A drug with a shape similar to the substrate can occupy the active site instead, so the enzyme cannot do its job: the drug is a competitive inhibitor. Example: many bacteria make the coenzyme folic acid from p-aminobenzoic acid (PABA), using the enzyme dihydropteroate synthase. Sulphanilamide, H₂N–C₆H₄–SO₂NH₂, closely resembles PABA, H₂N–C₆H₄–COOH, so it competes for that enzyme. The bacteria run short of folic acid, stop growing and may die. Humans obtain folic acid from food, so this pathway is not ours.

Other inhibitors bind at a different place on the enzyme, the allosteric site. Binding changes the shape of the active site so that the substrate no longer fits. These are allosteric inhibitors.

Two ways a drug can inhibit an enzyme

  • Competitive inhibitor
    • Shape similar to the substrate
    • Binds at the active site
    • Competes directly with the substrate
    • Sulphanilamide against PABA
  • Allosteric inhibitor
    • Shape need not resemble the substrate
    • Binds at a separate allosteric site
    • Changes the shape of the active site
    • Substrate can no longer bind

Receptors as drug targets

Most receptors are proteins built into the cell membrane, with their binding site facing outwards. A chemical messenger binds to the site, and the receptor passes the message into the cell. Receptors are very selective. A drug that binds to a receptor and blocks it is an antagonist; a drug that mimics the natural messenger and switches the receptor on is an agonist, useful when the natural messenger is lacking.

  • Adenosine binding to adenosine receptors brings on sleepiness. Caffeine is an antagonist: it binds to the same receptors without switching them on, so a person feels more awake.
  • Morphine is an agonist at opioid receptors: activating them suppresses the transmission of pain signals.
  • Receptors are chiral, so the two enantiomers of a chiral drug can have different effects.

Antagonist = binds and blocks the receptor; agonist = binds and activates it. Competitive inhibitor = occupies the enzyme's active site; allosteric inhibitor = binds elsewhere and changes the active site.

Worked example 2: comparing PABA and sulphanilamide

Compare the formulas and molar masses of PABA (C₇H₇NO₂) and sulphanilamide (C₆H₈N₂O₂S). (C = 12, H = 1, N = 14, O = 16, S = 32.) Working: PABA = 7 × 12 + 7 + 14 + 2 × 16 = 84 + 7 + 14 + 32 = 137 g mol⁻¹. Sulphanilamide = 6 × 12 + 8 + 2 × 14 + 2 × 16 + 32 = 72 + 8 + 28 + 32 + 32 = 172 g mol⁻¹. Both are benzene rings with –NH₂ at one end and an acidic group (–COOH or –SO₂NH₂) at the para position; the similar shape, not the mass, is what lets the drug fit the enzyme's active site.

Key takeaways: a medicine is a drug that acts on body macromolecules for a useful effect; a larger therapeutic index means a safer drug. Drugs are classified by structure, effect, target system and site of action. Drugs inhibit enzymes competitively or allosterically, and act on receptors as antagonists (blockers) or agonists (activators).

Check your understanding

  1. 1. Two drugs treat the same condition. Drug X has a therapeutic index of 15 and drug Y a therapeutic index of 4. Which statement is correct?

    1. Drug Y is safer because its index is smaller
    2. Drug X has a wider gap between its effective and toxic levels, so it is safer
    3. Both are equally safe
    4. The therapeutic index says nothing about safety
    Show answer

    Answer: B. The therapeutic index is the ratio of the highest tolerated level to the lowest effective level. A larger ratio means a wider safety margin, so drug X is the safer of the two.

  2. 2. How does sulphanilamide stop the growth of bacteria?

    1. It destroys the bacterial cell membrane
    2. It binds to adenosine receptors
    3. It acts as a competitive inhibitor of the enzyme that uses PABA to make folic acid
    4. It is an allosteric activator of folic acid synthesis
    Show answer

    Answer: C. Sulphanilamide resembles p-aminobenzoic acid, so it occupies the active site of dihydropteroate synthase. The bacteria cannot make enough folic acid and stop growing.

  3. 3. Caffeine reduces sleepiness by binding to adenosine receptors without activating them. Caffeine is therefore

    1. an agonist
    2. a competitive enzyme inhibitor
    3. an allosteric inhibitor
    4. an antagonist
    Show answer

    Answer: D. A drug that binds to a receptor and blocks the natural messenger is an antagonist. Adenosine would normally activate the receptor and cause sleepiness.

  4. 4. Which classification is the most specific, grouping drugs that share a mechanism?

    1. By molecular target (site of action)
    2. By chemical structure
    3. By pharmacological effect
    4. By colour or form
    Show answer

    Answer: A. Drugs that bind the same enzyme or receptor usually act by the same mechanism, so classification by site of action is the most specific. Grouping by effect is broad, and similar structures do not always give similar actions.

  5. 5. An inhibitor binds to an enzyme away from the active site and changes the shape of the active site. It is

    1. a competitive inhibitor
    2. an allosteric inhibitor
    3. an agonist
    4. a substrate
    Show answer

    Answer: B. Binding at a separate (allosteric) site that alters the active site is allosteric inhibition. A competitive inhibitor binds at the active site itself.

Sign in to keep track of the lessons you finish.

Next lesson → Therapeutic classes of drugs

Privacy · Terms · Refunds · Delivery